3 August 2021
Gendius to collaborate with The University of Manchester on new Human-AI research teams
Gendius has been selected to be a part of the new Human-AI research teams developed by the University of Manchester to help cure humanity's complex future health and societal problems through AI technology. Led by Professor Samuel Kaski from The University of Manchester, this...
2 August 2021
Infex Therapeutics sharpens Covid focus with new CRUK Newcastle partnership
Alderley Park, Cheshire – Infex Therapeutics is pressing ahead with a major development of its pandemic resilience strategy by today announcing an agreement with CRUK Newcastle Drug Discovery Unit. This will in-licence a novel therapy designed to treat SARS-CoV-2 along...
26 July 2021
Cytox strengthens team to support commercialisation of genoSCORE test to predict risk of cognitive decline due to Alzheimer’s disease
New appointments in Commercial Operations, Medical Affairs, and Bioinformatics & Genetics … 26 July 2021: Oxford & Manchester, UK. Cytox Ltd, which provides non-invasive, risk assessment and patient stratification tools for Alzheimer's disease and dementia, has...
14 July 2021
Women can buy Maxwellia’s Lovima® contraceptive pill from pharmacies for first time in UK history
WOMEN can now buy a contraceptive pill over the counter without a prescription following a consultation with a pharmacist after the UK’s Medicines and Healthcare products Regulatory Agency (MHRA) today granted a licence to Maxwellia’s Lovima®. … This...
7 July 2021
QV Bioelectronics raises £735k for development of implanted electric field therapy device for brain cancer treatment
6th July 2021, Cheshire, UK. QV Bioelectronics (“QV”) – a medical device start-up pioneering a first of its kind electric field therapy implant for the treatment of the most common and aggressive type of brain tumours, announces it has closed a £735,000...
5 July 2021
Gendius - new partnership will help diabetics to manage their conditions
Experts at the University of Nottingham have teamed up with digital health company Gendius Limited to help promote better care for people with diabetes … The University’s Digital Research Service will work with Gendius Limited to use diabetes data to develop and embed...
1 July 2021
Cambridge Cognition completes spin-out of Monument Therapeutics
Manchester, UK, July 1st, 2021: Monument Therapeutics, a stratified medicine company, today announced it has raised £2.625 million in seed funding to spin out of Cambridge Cognition Ltd and relocate to Alderley Park, Cheshire. The new company will focus on applying digital...
24 June 2021
Infinity BiologiX and Cytox collaborate to provide new genetic test to predict the risk of cognitive decline due to Alzheimer’s Disease
Powered by Cytox’s genoSCORE, the new test enables physicians to support patients with lifestyle changes, and guide possible use of drug therapy, to delay the onset of disease symptoms … PISCATAWAY, N.J. & OXFORD, England & MANCHESTER, England--(BUSINESS...
17 June 2021
Rinicare to provide continuous vital signs monitoring technology to Indian healthcare system
Manchester-based medtech start-up Rinicare has signed a deal with its distribution partner, Rinicom, to build and deliver an initial 100 units of its continuous vital signs monitoring technology to the Indian healthcare system. Corelink India will be distributing the units...
16 June 2021
Innovate UK funds AssistDent adaption for university dental schools
COVID-19 has placed major strains on dental schools where the practical, patient-orientated elements have faced significant challenges during lockdowns. Recognising the importance and ongoing impact of these issues Innovate UK, the UK’s innovation agency, has awarded...